Stocks and InvestingStocks and Investing
Tue, May 10, 2022
Mon, May 9, 2022
Fri, May 6, 2022

Jonathan Chang Maintained (BCYC) at Buy with Decreased Target to $69 on, May 6th, 2022


Published on 2024-10-27 20:53:45 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Bicycle Therapeutics plc" (BCYC) at Buy with Decreased Target from $70 to $69 on, May 6th, 2022.

Jonathan has made no other calls on BCYC in the last 4 months.



There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 2 agree with Jonathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kalpit Patel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $33 on, Wednesday, April 13th, 2022
  • Jeffrey Hung of "Morgan Stanley" Initiated at Hold and Held Target at $60 on, Monday, February 14th, 2022


These are the ratings of the 2 analyists that currently disagree with Jonathan


  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $75 on, Tuesday, April 12th, 2022
  • Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $70 on, Thursday, March 3rd, 2022